BHEL, Sun Pharma top Sensex losers
It was a tough week for Indian shares with the benchmark indexes bearing the brunt as the rupee tumbled to a fresh all-time low of 61.80 versus the dollar on Tuesday. Fears of the U.S. Federal Reserv
Indian drug firms okay with US law on enhanced inspection
The Indian generic drug industry is generally receptive to the proposed US law on medicine even though it seeks to enhance US-FDA inspection of the manufacturing facilities globally for a fee.
Indus
Sun Pharma gets favourable US Supreme Court verdict in patent case
Sun Pharmaceutical Industries on Wednesday said the US Supreme Court has given a favourable verdict in its patent case against Novo Nordisk over generic Prandin tablets used for treating diabetes.
US
BSE to include Coal India, Sun Pharma in Sensex
The premier stock exchange BSE would include Coal India and Sun Pharma in the Sensex effective from August 8, 2011. The opening bell ceremony to include Coal India in the BSE Sensex will be held on Mo
Indian drug major Sun Pharma takes control of Israeli Taro
Indian drug maker Sun Pharma has bought a controlling stake in Israeli Taro Pharmaceuticals after settling a prolonged legal battle with promoters of the acquired firm.
Sun, along with its subsidiari
Sun wins case against Israeli firm
Sun Pharma, which was fighting a takeover battle with Israeli pharma major Taro, on Wednesday said that the Supreme Court of Israel has given the ruling in favour of the company. The Court has unanimo
Sun wins patent case against Eli Lily over cancer drug
New Delhi, July 29: Sun Pharma today claimed victory over Eli Lily and Co in a patent litigation over Gemzar, used in cancer treatment, with a US federal court ruling in its favour.
Eli Lily had cont